The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment

Asher Ornoy; Rivka Wajnberg; Orna Diav-Citrin

doi:10.1016/j.reprotox.2006.05.009

The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment

Asher Ornoy^*
, Rivka Wajnberg
, Orna Diav-Citrin

^*Corresponding author for this work

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Abstract

In spite of a substantial increase in the use of bisphosphonates at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 24 pregnancies after pre-pregnancy or early pregnancy alendronate therapy. Based on the pregnancy outcome it seems that alendronate does not impose a major teratogenic risk.

Original language	English
Pages (from-to)	578-579
Number of pages	2
Journal	Reproductive Toxicology
Volume	22
Issue number	4
DOIs	https://doi.org/10.1016/j.reprotox.2006.05.009
State	Published - Nov 2006

Keywords

Alendronate
Pregnancy outcome

Access to Document

10.1016/j.reprotox.2006.05.009

Cite this

@article{4dfb83fa66bc478aa2725cea4de26301,

title = "The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment",

abstract = "In spite of a substantial increase in the use of bisphosphonates at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 24 pregnancies after pre-pregnancy or early pregnancy alendronate therapy. Based on the pregnancy outcome it seems that alendronate does not impose a major teratogenic risk.",

keywords = "Alendronate, Pregnancy outcome",

author = "Asher Ornoy and Rivka Wajnberg and Orna Diav-Citrin",

year = "2006",

month = nov,

doi = "10.1016/j.reprotox.2006.05.009",

language = "אנגלית",

volume = "22",

pages = "578--579",

journal = "Reproductive Toxicology",

issn = "0890-6238",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment

AU - Ornoy, Asher

AU - Wajnberg, Rivka

AU - Diav-Citrin, Orna

PY - 2006/11

Y1 - 2006/11

N2 - In spite of a substantial increase in the use of bisphosphonates at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 24 pregnancies after pre-pregnancy or early pregnancy alendronate therapy. Based on the pregnancy outcome it seems that alendronate does not impose a major teratogenic risk.

AB - In spite of a substantial increase in the use of bisphosphonates at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 24 pregnancies after pre-pregnancy or early pregnancy alendronate therapy. Based on the pregnancy outcome it seems that alendronate does not impose a major teratogenic risk.

KW - Alendronate

KW - Pregnancy outcome

UR - https://www.scopus.com/pages/publications/33749595622

U2 - 10.1016/j.reprotox.2006.05.009

DO - 10.1016/j.reprotox.2006.05.009

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 16996245

AN - SCOPUS:33749595622

SN - 0890-6238

VL - 22

SP - 578

EP - 579

JO - Reproductive Toxicology

JF - Reproductive Toxicology

IS - 4

ER -

The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this